GSK suspends all ranitidine containing products in the market

MG News | September 26, 2019 at 11:57 AM GMT+05:00

0:00

September 26, 2019 (MLN): GlaxoSmithKline Pakistan Limited (GSK), has announced to suspend the release, distribution and supply of all dose forms of ranitidine hydrochloride products to all markets including Pakistan, after being contacted by regulatory authorities regrading the detection of genotoxic nitrosamine NDMA in ranitidine products.

The decision was taken as a precautionary action pending the outcome of ongoing tests and investigations, revealed an official notification sent by the company to the exchange.

As per the notification, GSK Pakistan has proactively informed the Drug Regulatory Authority of Pakistan (DRAP) about the above-mentioned decision. Subsequently, the DRAP has advised Pharma companies to recall all ranitidine containing products in the market till further orders.

Copyright Mettis Link News

Related News

Name	Price/Vol	%Chg/NChg
KSE100	134,299.77 290.06M	0.39% 517.42
ALLSHR	84,018.16 764.12M	0.48% 402.35
KSE30	40,814.29 132.59M	0.33% 132.52
KMI30	192,589.16 116.24M	0.49% 948.28
KMIALLSHR	56,072.25 387.69M	0.32% 180.74
BKTi	36,971.75 19.46M	-0.05% -16.94
OGTi	28,240.28 6.19M	0.21% 58.78

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	118,140.00	119,450.00 115,635.00	4270.00 3.75%
BRENT CRUDE	70.63	70.71 68.55	1.99 2.90%
RICHARDS BAY COAL MONTHLY	97.50	0.00 0.00	1.10 1.14%
ROTTERDAM COAL MONTHLY	108.75	108.75 108.75	0.40 0.37%
USD RBD PALM OLEIN	998.50	998.50 998.50	0.00 0.00%
CRUDE OIL - WTI	68.75	68.77 66.50	2.18 3.27%
SUGAR #11 WORLD	16.56	16.60 16.20	0.30 1.85%